Spark Investment Management’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Spark Investment Management’s Portfolio JNCE Stock Details JNCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-12,200	Closed	-$60K	–	547
2019 Q2	$60K	Sell	12,200 -232,100	-95%	-$1.23M	﹤0.01%	525
2019 Q1	$1.51M	Sell	244,300 -35,600	-13%	-$172K	0.07%	292
2018 Q4	$943K	Buy	279,900 +20,043	+8%	+$93.6K	0.07%	326
2018 Q3	$1.69M	Buy	259,857 +44,157	+20%	+$328K	0.1%	292
2018 Q2	$1.65M	Buy	215,700 +155,300	+257%	+$2.24M	0.1%	278
2018 Q1	$1.35M	Sell	60,400 -90,100	-60%	-$2M	0.09%	288
2017 Q4	$1.92M	Sell	150,500 -11,700	-7%	-$172K	0.1%	274
2017 Q3	$2.53M	Buy	162,200 +36,900	+29%	+$522K	0.14%	226
2017 Q2	$1.76M	Buy	125,300 +64,100	+105%	+$1.37M	0.11%	272
2017 Q1	$1.34M	Buy	+61,200	New	+$1.3M	0.09%	345

Other funds holding JNCE

TGI

TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return

TGI

TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Spark Investment Management's JNCE Position: Q3 2019 in Review

Spark Investment Management sold out of Jounce Therapeutics, Inc. Common Stock (JNCE) in Q3 2019, closing a stake of 12,200 shares — an estimated $60K sold.

Spark Investment Management first reported a position in JNCE in Q1 2017 and held it in 10 quarters. The position peaked at $2.53M in Q3 2017. 77 funds tracked by Wall St. Rank hold JNCE as of Q3 2019.

Spark Investment Management reported no remaining Jounce Therapeutics, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
Spark Investment Management sold 12,200 Jounce Therapeutics, Inc. Common Stock shares in Q3 2019, an estimated $60K.
Spark Investment Management first reported a position in Jounce Therapeutics, Inc. Common Stock in Q1 2017 and held it in 10 quarters.
Spark Investment Management's Jounce Therapeutics, Inc. Common Stock position peaked at $2.53M in Q3 2017.
77 funds tracked by Wall St. Rank held Jounce Therapeutics, Inc. Common Stock as of Q3 2019.

Based on Spark Investment Management's 13F filing for Q3 2019, filed 12 Nov 2019.